Objective To construct dendritic cell(DC) vaccine expressing hepatitis C virus(HCV) multi-cytotoxic T lymphocyte(CTL) epitopes,which can stimulate T-cell response in vitro,providing certain information for immunization experiments in vivo for the next step.Methods DCs were infected with recombinant defective adenoviruses expressing two HCV CTL epitopes with tagged green fluorescent protein(GFP).The rate of infection was detected by the fluorescence microscope or flow cytometry;the expression of multiple CTL epitopes in DC was proved by RT-PCR and Western Blot.The cell surface markers of DC such as CD80,CD83,CD86 and HLA-DR were identified by flow cytometry.T cell proliferation effect promoted by DC was observed by cell counting kit-8(CCK-8).IL-12p70 in DC culture supernatant and IFN-γ in T cell supernatant were detected by Enzyme-Linked Immuno Sorbent Assay(ELISA).HCV specific CTL activity was measured by LDH release assay.Results Recombinant multi-CTL epitopes and GFP were successfully expressed in DC.Adenovirus can promote DC maturation,the percentages of CD80,CD83,CD86 and HLA-DR were(71.19±3.29)%,(81.21±5.07)%,(91.23±4.24)%,(97.95±5.31)% respectively.Infected DC promotes homologous T cell proliferation and the stimulation index was 6.806±0.247 when DC:T was 1:10.The secretion of IL-12 and IFN-γ was also increased to(193.83±6.25) pg/ml and(111.14±2.09) pg/ml respectively.The CTL stimulated by infected DC could specifically kill Huh-7.5 cells transfected with FL-J6/JFH transcripts.The cytotoxicity was 35.99% when the rate of effector to target was 100:1.Conclusion The multi-CTL epitopes recombinant adenovirus can effectively infect DC in vitro,promoting the T cell immune response,laying the foundation for developing anti-HCV DC vaccine.
[1]Stoll-Keller F,Barth H,Fafi-Kremer S,et al.Development of hepatitis C virus vaccines:challenges and progress[J].Expert Rev Vaccines,2009,8(3):333-345.
|
[2] 李端,薛小平,贾战生,等.中国人HCV CTL复合多表位抗原基因免疫学特性研究[J].中华肝脏病杂志,2009,17(10):786-787.
|
[3]张美先,李勤凡,李端,等.中国人丙型肝炎病毒CTL多表位肽诱发的细胞免疫应答[J].细胞与分子免疫学杂志,2010,5(26):400-402.
|
[4]马力,魏欣,张野,等.体外培养的嵌合体丙型肝炎病毒感染Huh7.5细胞的透射电镜观察[J].中华微生物学和免疫学杂志,2009,29(6):568-573.
|
[5]Steinman RM,Banchereau J.Taking dendritic cells into medicine[J].Nature,2007,449(7161):419-426.
|
[6]Lundqvist A,Noffz G,Pavlenko M,et al.Nonviral and vral gene transfer into different subsets of human dendritic cells yield comparable efficiency of transfection[J].J Immunotherapy,2002,25(6):445-454.
|
[7]Diepolder HM,Gerlach JT,Zachoval R,et al.Imm-unodominant CD4+T-cell epitope within nonstructural protein 3 in acute hepatitis C virus infection[J].J Virol,1997,71(8):6011-6019.
|
[8]Wang QM,Sun SH,Hu ZL,et al.Epitope DNA vaccines against tuberculosis:spacers and ubiquitin modulates cellular immune responses elicited by epitope DNA vaccine[J].Scand J Immunol,2004,60(3):219-225.
|
[9]Cerny A,McHutchison JG,Pasquinelli C,et al.Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif[J].J Clin Invest,1995,95(2):521-530.
|
[1] | Shao Xue, Ma JingTing, Song Jie, Zhang Qian, Zhang ChuanHui, Wang WuDong, Wu Meng, Pan LiuLan. Construction of the eukaryotic expression vectors of interleukin-12 and granulocyte-macrophage colony-stimulating factor and their expression in hepatoma cells[J]. Journal of Clinical Hepatology, 2018, 34(7): 1487-1491. doi: 10.3969/j.issn.1001-5256.2018.07.024 |
[2] | Cao ZhenHuan, Liu YaLi, Ma LiNa, Lu JunFeng, Jin Yi, He ZhiMin, Zheng YanHong, Chen XinYue. Association between serum level of interleukin-17 and HBsAg clearance in patients with HBsAg-negative chronic hepatitis B[J]. Journal of Clinical Hepatology, 2016, 32(7): 1292-1295. doi: 10.3969/j.issn.1001-5256.2016.07.015 |
[3] | Zhou Liang, Li XiaoYan, Huang YueHua. Regulatory effect of interleukin-10 on natural killer cells in patients with chronic hepatitis B[J]. Journal of Clinical Hepatology, 2016, 32(8): 1600-1603. doi: 10.3969/j.issn.1001-5256.2016.08.040 |
[4] | Shi QingFeng, Zhang YingXin, Song JiKui, Yuan JianGuo, Li QingFang, Zhao HongKui, Ceng WeiQun, Chen Min. Effect of prostaglandin E1 on the dendritic cells maturation and the activity of CD4+/CD8+ T cells in chronic severe hepatitis B patients[J]. Journal of Clinical Hepatology, 2012, 28(3): 212-215. |
[5] | Jiang ShuLian, Tan ShanZhong, Wen Jian. Role of CD4+CD25+ T regulatory cells in HBeAg seroconversion during interferon antiviral[J]. Journal of Clinical Hepatology, 2012, 28(7): 528-530. |
[6] | Wei Feng, Li JunQing, Zhou JunYing. Dendritic cells and hepatitis C[J]. Journal of Clinical Hepatology, 2011, 27(5): 549-552. |
[7] | Huang ZhongFa, Zhu Qing, Fu QiMei, Bu QuanHui, Shi BinBin. The effect of Interferon treatment on cellular immuneresponses in patients with chronic hepatitis B[J]. Journal of Clinical Hepatology, 2009, 25(5): 326-328. |
[8] | Dong JiaXiu, Zhao ShouSong, Gao JiJun, Jiao XianChun, Li BoQing, Jin QiLi, Cui Zhuo. Sdudy the relationship between serum hepatitis B virus deoxyribonucleic acid and circulating dendritic cell subsets in patients with hepatitis B infection[J]. Journal of Clinical Hepatology, 2009, 25(3): 167-170. |
[10] | Hu Yan, Wan Jie, Ou YangShaoXia. Role of serum interleukin-12 and tumor necrosis factor on human viral hepatitis.[J]. Journal of Clinical Hepatology, 2007, 23(5): 353-355. |
[14] | Wang ZhiHong, Yue Bei, Lin LanYi, Xu Jie, Yu JianWu, Lu: ShuLan. Clinical study of acupuncture and interferon-α treatment in patients with chronic hepatitis B.[J]. Journal of Clinical Hepatology, 2002, 18(3): 187-188. |
[16] | Zhang MingWei, Zhang Jing, Zhao ZhengHong. Dentritic cell infiltration and PCNA expression in gallbladder carcinoma and their significances.[J]. Journal of Clinical Hepatology, 2002, 18(5): 288-289. |